Key Highlights

  • CoreCivic closed down 6.49% at $32.13 after President and CEO Patrick Swindle resigned to seek treatment for stage four pancreatic cancer.
  • Lucibeth Mayberry was named his successor, providing an immediate succession plan.
  • CoreCivic remains up sharply year-to-date despite the day's decline, with trailing-twelve-month Revenue reaching $2.48 billion, up 24.3% year over year.

CoreCivic (NYSE:CXW) closed down 6.49% at $32.13 after President and CEO Patrick Swindle resigned to seek treatment for stage four pancreatic cancer, with Lucibeth Mayberry named his successor. The abrupt Leadership transition adds company-specific uncertainty to a stock that remains up sharply year-to-date, despite an analyst consensus of Strong Buy.

CEO Exit Sends CXW Lower

Mayberry's appointment supplied an immediate succession plan, but the market reaction showed that naming a replacement did not prevent a sharp repricing. CoreCivic's decline was large relative to its normal daily trading range. The combination of a sudden executive transition and a move materially larger than typical daily Volatility makes continuity under Mayberry the immediate investor issue.

Thin Volume Amplifies the Leadership Shock

Trading volume was well below a typical full session, meaning the decline came on lighter participation than a normal day. Geo Group fell 4.5%, Brinks declined 0.8%, and Knightscope was little changed, a peer comparison that classifies the move as company-specific rather than a sector-wide selloff. CXW is down over the past month even as it remains up sharply year-to-date, with a 52-week range that places the current price well above its low and below its high.

Momentum Weakens Below Key Averages

The shorter-term trend is weaker than the longer-term position, rather than showing a break beneath every major average. Momentum readings were also soft: the 14-day RSI was 43.1, and MACD at 0.00 sat below its 0.37 signal line. ADX was 14.3, indicating the move lacked a strong trend-strength reading. The nearest downside reference is first support at $29.53, followed by $25.83. On the upside, first resistance is $35.89, with $38.55 next above it.

Revenue Growth Meets a Leveraged Balance Sheet

Trailing-twelve-month revenue is $2.48 billion, up 24.3% year over year, with a gross Margin of 17.1%, Operating Margin of 9.9%, and net margin of 5.1%. Return on Equity is 8.8%, while the Debt-to-Equity Ratio is 0.94. The Balance Sheet shows $1.36 billion of reported debt against $108.93 million of cash and equivalents. Valuation measures include a trailing P/E of 25.2, a price-to-sales ratio of 1.3, and a Price-to-Book Ratio of 2.2.

Peers Moving on This News